<DOC>
	<DOCNO>NCT00812851</DOCNO>
	<brief_summary>Many patient ALS experience cramp course disease . Frequently , cramp occur first symptom disease , month patient notice weakness wasting . Cramp severity varies mild , without affect daily activity sleep , disable , almost voluntary muscle activity induces long stand , severely painful cramping . ALS patient smoke herbal cannabis ( marijuana ) drink hemp tea report lessen cramps fasciculation . Although , various medication , magnesium , quinine sulfate , lioresal , dantrolene , clonazepam , diphenylhydantoin gabapentin use treatment cramp ALS far , medication proven benefit . However , recent pilot study THC ALS show symptomatic effect `` spasm '' , fasciculation , insomnia appetite . The aim propose study determine tolerability , safety efficacy THC treatment cramp ALS . The hypothesis THC lessen cramps ALS .</brief_summary>
	<brief_title>Randomized Placebo-Controlled Crossover Trial With THC ( Delta 9-Tetrahydrocannabinol ) Treatment Cramps Amyotrophic Lateral Sclerosis ( ALS )</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Muscle Cramp</mesh_term>
	<mesh_term>Spasm</mesh_term>
	<mesh_term>Dronabinol</mesh_term>
	<criteria>Patients must least 18 year age full legal capacity Patients must voluntarily give write informed consent Patients diagnose possible , probable laboratory support , probable definite ALS accord revise El Escorial criterion ( Brooks 2000 ) Patients must score severity cramp VAS 5 Patients must able communicate report adverse event phone Patients must laboratory parameter within follow limit : Creatinine , Bilirubin , Transaminases le 3x upper limit normal Patients may take medication treatment ALS ( ALS specific symptomatic ) may change medication study period Patients must cannabis cannabinoids least one month prior study agree use study . They negative urinary test cannabinoids baseline Premenopausal female must provide negative pregnancy test within fourteen day begin study participation apply adequate ( barrier ) birthcontrol method Patients must agree drive vehicle use dangerous machine entire study period Patients willing able sign consent form . Doubt investigator concern compliance patient Patients history failure respond , significant adverse effect hypersensitivity THC cannabinoid Patients significant concomitant illness ( e ) , acute , uncontrolled infection , might make evaluation treatment side effect difficult Patients history significant psychiatric disorder , explicitly schizophrenia Patients current drug abuser , include alcohol abuser Patients severe coronary artery disease hemodynamically relevant ECGdocumented arrhythmia Pregnancy breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>ALS</keyword>
	<keyword>cramp</keyword>
	<keyword>THC</keyword>
	<keyword>Dronabinol</keyword>
</DOC>